(Q40514319)

English

IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C.

scientific article published on 6 October 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Mohammad Reze Aghasadeghi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Parvaneh Sedighimehr

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Fatemeh Sakhaee

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Seyed Mehdi Sadat

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Fatemeh Rahimi Jamnani

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Abolfazl Fateh

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Seyed Davar Siadat

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

6 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Archives of Virology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

162

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

181-189

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27714501%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

https://scigraph.springernature.com/pub.10.1007/s00705-016-3095-1

0 references

Hepatitis C pharmacogenetics: state of the art in 2010.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Comparison of Three Different Methods for Detection of IL28 rs12979860 Polymorphisms as a Predictor of Treatment Outcome in Patients with Hepatitis C Virus.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Alleles at rs4273729 in the chromosome 6 do not predict response to peg-interferon-α and ribavirin therapy in hepatitis C virus/HIV-1-coinfected patients

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Genetic variant of IL28B rs12979860, as predictive marker of interferon-based therapy in Pakistani population

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

The genotype CC of IL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

EASL recommendations on treatment of hepatitis C 2014.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Interleukin- 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

IL28B rs12980275 polymorphism shows association with response to treatment in Pakistani patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

A genetic variant in the interleukin 28B gene as a major predictor for sustained virologic response in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Epidemiology of hepatitis C virus in Iran

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-016-3095-1

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40514319&oldid=1496162548"